(redirected from Stevens-Johnson syndrome)
Also found in: Dictionary, Medical, Encyclopedia, Wikipedia.
Related to Stevens-Johnson syndrome: erythema multiforme
Graphic Thesaurus  🔍
Display ON
Animation ON
  • noun

Synonyms for syndrome

Words related to syndrome

References in periodicals archive ?
Comprehensive survival analysis of a cohort of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis.
Although rare in the pediatric population--with an incidence of approximately 1 case in 2 million Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are both life-threatening mucocutaneous reactions.
Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are life-threatening diseases characterized by widespread red rash, blisters, and shedding of dead skin, with mucosal involvement.
An analysis of drug induced Stevens-Johnson syndrome.
Erythema multiforme with mucous membrane involvement and Stevens-Johnson syndrome are clinically different disorders with distinct causes.
Results: Two of the patients had Stevens-Johnson syndrome, four had Stevens-Johnson syndrome/toxic epidermal necrolysis overlap, and five had toxic epidermal necrolysis.
Halle-Grace did not have scarlet fever but had developed Stevens-Johnson syndrome, a reaction to her medication that causes blisters and eventually sees affected skin die and shed.
Although it has a small incidence, Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis can attack all races in all ages, with men and women ratio 3:5 and had high mortality rate.
The allergic reaction is life-threatening and is called Stevens-Johnson Syndrome.
It was there she was diagnosed with Stevens-Johnson Syndrome - a rare condition caused by a violent allergic reaction to a virus or a medication which affects just 1 in 50,000 people.
He developed Stevens-Johnson syndrome (SJS), which progressed to toxic epidermal necrolysis (TEN) and death over a period of 26 days.
The presence of generalized blistering and systemic symptoms would suggest conditions related to medication exposure, such as Stevens-Johnson syndrome or toxic epidermal necrolysis; infectious etiologies (eg, staphylococcal scalded skin syndrome); autoimmune causes; or underlying malignancy.
His teams aims, were to design and test the reliability of a new tool for grading LSCD, to define a set of core outcome measures to use in evaluating treatments to demonstrate the treatments' impact on two common types of LSCD: a genetic disorder called aniridia and Stevens-Johnson syndrome (SJS), an inflammatory disorder.